Experienced telehealth and obesity physicians support access-maximizing asynchronous care pathways and evidence-based lab flows
My doctor walked me through the maintenance plan before I asked. Theo R
However, a large Taiwanese cohort study of 11.7 million obese individuals found that GLP-1 RAs, particularly semaglutide, were associated with increased risk of depression, anxiety, and suicidal behavior [10]
Wegovy (semaglutide) is an FDA-approved prescription medication used for chronic weight management in adults with obesity or excess weight
New drugs like Prolonix (Phase III trials) mimic amylin, showing 25% greater craving reduction than GLP-1 agonists alone
Mochi emphasizes accessibility and affordability, often marketing lower price points than branded alternatives